Skip to content
Invitrocue - Transforming bioanalytics
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)

ASX Announcements

Appendix 3B – December 2018

December 17, 2018

Appendix 3B

Categories ASX Announcements

Cleansing Statement – December 2018

December 17, 2018

Cleaning Statement

Categories ASX Announcements

Results of Annual General Meeting

November 30, 2018

Results of Annual General Meeting 2018

Categories ASX Announcements, News

Dr Lindner as Europe CEO and Prof Waugh as Senior Advisor

November 19, 2018

Dr Lindner as Europe CEO and Prof Waugh as Senior Advisor

Categories ASX Announcements, News

Quarterly Appendix 4C and Business updates

November 1, 2018

Quarterly Appendix 4C and Business updates

Categories ASX Announcements, Financial Reports

Notice of Annual General Meeting/Proxy Form

October 30, 2018

Notice of Annual General Meeting/Proxy Form

Categories ASX Announcements

Initial Director's Interest Notice – Dr Gary W Pace

October 23, 2018

Initial Director’s Interest Notice – Dr Gary W Pace

Categories ASX Announcements

Appointment of Dr. Gary W. Pace as director

October 23, 2018

Appointment of Dr. Gary W. Pace as director

Categories ASX Announcements

Assoc Prof Iyer as Chair of IVQ Medical Advisory Board

October 22, 2018

Assoc Prof Iyer as Chair of IVQ Medical Advisory Board

Categories ASX Announcements, News

Annual Report to shareholders

September 28, 2018

Annual Report to shareholders

Categories ASX Announcements, News
Post navigation
Older posts
Newer posts
← Previous Page1 … Page5 Page6 Page7 … Page16 Next →

Recent Posts

  • Strategic partnership & Financial advisor appointment
  • Invitrocue announces acquisition of Welala to create life science leadership in Thailand and Asean
  • Invitrocue’s Onco-PDO test is Singapore’s and world’s first validated and approved Clinical Cancer Drug Screening service for Personalised Oncology
  • Operational Updates – February 2024
  • Operational Updates – October 2023

GET IN TOUCH

51 Science Park Road, #01-11/13 The Aries, Singapore Science Park II Singapore 117586

GENERAL / PHARMACOLOGY ENQUIRIES:

+65 6460 0497
contact@invitrocue.com

ONCO-PDO ENQUIRIES:

+65 6819 0181
onco-pdo@invitrocue.com
SAC - SINGLAS Accredited Laboratory

SERVICES

Home
About Us
Oncology
Preclinical Services
Investors
News & Resources
Contact Us

Logo Invitrocue
Icon-twitter-x Facebook-f Linkedin-in Youtube

© Copyright 2026 Invitrocue. All rights reserved
Impressum | Privacy Policy | Cookies Policy | Cookie Settings